Treatment of Hypertension with Nutrition and Nutraceutical Supplements: Part 2

Houston M . The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol, 2014; 6:38–66.

Houston M . Nutrition and nutraceutical supplements for the treatment of hypertension: Part 1. J Clin Hypertens, 2013; 15:752–757.

Houston M . Nutrition and nutraceutical supplements for the treatment of hypertension: Part II. J Clin Hypertens, 2013; 15:845–851.

Houston M . Nutrition and nutraceutical supplements for the treatment of hypertension: Part III. J Clinical Hypertens, 2013; 15:931–937.

Hanni LL , Huarfner LH , Sorensen OH , Ljunghall S . Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens, 1995; 8:894–901.

Bednarski R , Donderski R , Manitius L . Role of Vitamin D in arterial blood pressure control. Pol Merkur Lekarski, 2007; 136:307–310.

Li YC , Kong H , Wei M , Chen ZF . 1, 25 Dihydroxyvitamin D 3 is a negative endocrine regulator of the renin angiotensin system. J Clin Invest, 2002; 110:229–238.

Ngo DT , Sverdlov AL , McNeil JJ , Horowitz JD . Does vitamin D modulate asymmetric dimethylargine and C-reactive protein concentrations?. Am J Med, 2010; 123:335–341.

Rosen CJ . Clinical practice. Vitamin D insufficiency. N Engl J Med, 2011; 20;364:248–254.

Boldo A , Campbell P , Luthra P , White WB . Should the concentration of vitamin D be measured in all patients with hypertension?. J Clin Hypertens, 2010; 12:149–152.

Pittas AG , Chung M , Trikalinos T , et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med, 2010; 152:307–314.

Movano Peregrin C , Lopez Rodriguez R , Castilla Castellano MD . Vitamin D and hypertension. Med Clin (Barc), 2011; 138:397–401.

Motiwala SR , Wang TJ . Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens, 2011; 20:345–353.

Cosenso-Martin LN , Vitela-Martin JF . Is there an association between vitamin D and hypertension. Recent Pat Cardiovasc Drug Discov, 2011; 6:140–147.

Bhandari SK , Pashayan S , Liu IL , et al. 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens, 2011; 13:170–177.

Pfeifer M , Begerow B , Minne HW , et al. Effects of a short-term vitamin D (3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab, 2001; 86:1633–1637.

Qi D , Nie XL , Wu S . Vitamin D and hypertension: Prospective study and meta-analysis. PLoS One, 2017; 12:e017429–8.

McMullan CJ , Borgi L , Curhan GC , et al. The effect of vitamin D on renin–angiotensin system activation and blood pressure: A randomized control trial. J Hypertens, 2017; 35:822–829.

Qi D , Nie X , Cai J . The effect of vitamin D supplementation on hypertension in non-CKD populations: A systemic review and meta-analysis. Int J Cardiol, 2017; 227:177–186.

Yilmaz S , Sen F , Ozeke O , et al. The relationship between vitamin D levels and nondipper hypertension. Blood Press Monit, 2015; 20:330–334.

Beveridge LA , Struthers AD , Khan F , et al. Effect of vitamin D supplementation on blood pressure: A systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med, 2015; 175:745–754.

Forman JP , Scott JB , Ng K , et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension, 2013; 61:779–785.

McMullan CJ , Borgi L , Curhan GC , et al. The effect of vitamin D on renin–angiotensin system activation and blood pressure: A randomized control trial. J Hypertens, 2017; 35:822–829.

Keniston R , Enriquez JI Sr . Relationship between blood pressure and plasma vitamin B₆ levels in healthy middle-aged adults. Ann N Y Acad Sci, 1990; 585:499–501.

Aybak M , Sermet A , Ayyildiz MO , Karakilcik AZ . Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung, 1995; 45:1271–1273.

Paulose CS , Dakshinamurti K , Packer S , Stephens NL . Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat. Hypertension, 1988; 11:387–391.

Dakshinamurti K , Lal KJ , Ganguly PK . Hypertension, calcium channel and pyridoxine (vitamin B 6). Mol Cell Biochem, 1998; 188:137–148.

Noori N , Tabibi H , Hosseinpanah F , et al. Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy. Int J Vitam Nutr Res, 2013; 83:77–85.

Moline J , Bukharovich IF , Wolff MS , Phillips R . Dietary flavonoids and hypertension: Is there a link?. Med Hypotheses, 2000; 55:306–309.

Knekt P , Reunanen A , Jä rvinen R , et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol, 1994; 139:1180–1189.

Karatzi KN , Papamichael CM , Karatizis EN , et al. Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery disease patients. Am J Hypertens, 2005; 18:1161–1167.

Biala A , Tauriainen E , Siltanen A , et al. Resveratrol induces mitochondrial biogenesis and ameliorates Ang II- induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood Press, 2010; 19:196–205.

Wong RH , Howe PR , Buckley JD , et al. Acute resveratrol supplementation improves flow-mediated dilatation in overweight obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis, 2011; 21:851–856.

Bhatt SR , Lokhandwala MF , Banday AA . Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol, 2011; 667:258–264.

Rivera L , Moron R , Zarzuelo A , Galisteo M . Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol, 2009; 77:1053–1063.

Sahebkar A , Ferri C , Giorgini P , et al. Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res, 2017; 115:149–161.

Tjelle TE , Holtung L , Bø hn SK , et al. Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers. Br J Nutr, 2015; 114:1054–1063.

de Jesús Romero-Prado MM , Curiel-Beltrán JA , Miramontes-Espino MV , et al. Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure. Basic Clin Pharmacol Toxicol, 2015; 117:57–64.

Asgary S , Sahebkar A , Afshani MR , et al. Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother Res, 2014; 28:193–199.

Borghi C , Cicero AF . Nutraceuticals with a clinically detectable blood pressure-lowering effect: A review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol, 2017; 83:163–171.

Sirtori CR , Arnoldi A , Cicero AF . Nutraceuticals for blood pressure control. Review. Ann Med, 2015; 47:447–456.

Cicero AF , Colletti A . Nutraceuticals and blood pressure control: Results from clinical trials and meta-analyses. High Blood Press Cardiovasc Prev, 2015; 22:203–213.

Turner JM , Spatz ES . Nutritional supplements for the treatment of hypertension: A practical guide for clinicians. Curr Cardiol Rep, 2016; 18:12–6.

Caligiuri SP , Pierce GN . A review of the relative efficacy of dietary, nutritional supplements, lifestyle and drug therapies in the management of hypertension. Crit Rev Food Sci Nutr, 2017; 57:3508–3527.

Houston MC , Fox B , Taylor N . What Your Doctor May Not Tell You About Hypertension. The Revolutionary Nutrition and Lifestyle Program to Help Fight High Blood Pressure. New York: AOL Time Warner, Warner Books, 2003.

Houston MC . Handbook of Hypertension. Oxford: Wiley-Blackwell, 2009.

Houston MC . What Your Doctor May Not Tell You About Heart Disease. New York: Grand Central Press, 2012.

Sinatra S , Houston M , eds. Nutrition and Integrative Strategies in Cardiovascular Medicine. Boca Raton, FL: CRC Press, 2015.

Paran E , Engelhard YN . Effect of lycopene, an oral natural antioxidant on blood pressure. J Hypertens, 2001; 19:S7–4.

Engelhard YN , Gazer B , Paran E . Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: A double blind placebo controlled pilot study. Am Heart J, 2006; 151:10–0.

Paran E , Novac C , Engelhard YN , Hazan-Halevy I . The effects of natural antioxidants form tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther, 2009; 23:145–151.

Reid K , Frank OR , Stocks NP . Dark Chocolate or tomato extract for prehypertension: A randomized controlled trial. BMC Complement Altern Med, 2009; 9:2–2.

Paran E , Engelhard Y . Effect of tomato's lycopene on blood pressure, serum lipoproteins, plasma homocysteine and oxidative stress markers in grade I hypertensive patients. Am J Hypertens, 2001; 14:141–A.

Ried K , Fakler P . Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas, 2011; 68:299–310.

Burton-Freeman B , Sesso HD . Whole food versus supplement: Comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Adv Nutr, 2014; 5:457–485.

Langsjoen PH , Langsjoen AM . Overview of the use of CoQ10 in cardiovascular disease. Biofactors, 1999; 9:273–284.

Singh RB , Niaz MA , Rastogi SS , et al. Effect of hydrosoluble coenzyme Q10 on blood pressure and insulin resistance in hypertensive patients with coronary heart disease. J Hum Hypertens, 1999; 12:203–208.

Burke BE , Neustenschwander R , Olson RD . Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J, 2001; 94:1112–1117.

Rosenfeldt FL , Haas Sj , Krum H , Hadu A . Coenzyme Q 10 in the treatment of hypertension: A meta-analysis of the clinical trials. J Hum Hypertens, 2007; 21:297–306.

Singh RB , Niaz MA , Rastogi SS , et al. Effect of hydrosoluble coenzyme Q 10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens, 1999; 13:302–308.

Ankola DD , Viswanas B , Bhardqaj V , et al. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplement be used as first line therapeutic agents for prophylaxis/therapy?. Eur J Pharm Biopharm, 2007:67:361–369.

Ho MJ , Li EC , Wright JM . Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev, 2016; 3:CD00743–5.

Ho MJ , Bellusci A , Wright JM . Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev, 2009; 4:CD007435.

Mikhin VP , Kharchenko AV , Rosliakova EA , Cherniatina MA . Application of coenzyme Q(10) in combination therapy of arterial hypertension. Kardiologiia, 2011; 51:26–31.

Tsai KL , Huang YH , Kao CL , et al. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem, 2012; 23:458–468.

Sohet FM , Delzenne NM . Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity?. Nutr Rev, 2012; 70:631–641.

Digiesi V , Cantini F , Oradei A , et al. Coenzyme Q10 in essential hypertension. Mol Aspects Med, 1994; 15:s257–s263.

Langsjoen P , Langsjoen P , Willis R , Folkers K . Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med, 1994; 15:S265–S272.

Trimarco V , Cimmino CS , Santoro M , et al. Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension. High Blood Press Cardiovasc Prev, 2012; 19:117–122.

Young JM , Florkowski CM , Molyneux SL , et al. A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. Am J Hypertens, 2012; 2:261–270.

Kontush A , Reich A , Baum K , et al. Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. Atherosclerosis, 1997; 129:119–126.

McLachlan J , Beattie E , Murphy MP , et al. Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function. J Hypertens, 2014; 32:555–564.

Rosenfeldt F , Hilton D , Pepe S , Krum H . Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors, 2003; 18:91–100.

Wesa KM , Grimm RH . Recommendations and guidelines regarding the preferred research protocol for investigating the impact of an optimal healing environment on patients with hypertension. J Altern Complement Med, 2004; 10:S245–S250.

McMackin CJ , Widlansky ME , Hambury NM , Haung AL . Effect of combined treatment with alpha lipoic acid and acetyl carnitine on vascular function and blood pressure in patients with coronary artery disease. J Clin Hypertens, 2007:9:249–255.

Hatzitolios A , Iliadis F , Katsiki N , Baltazi M . Is the anti-hypertensive effect of dietary supplements via aldehydes reduction evidenced based? A systematic review. Clin Exp Hypertens, 2008; 30:628–639.

Salinthone S , Schillace RV , Tsang C , et al. Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms. J Nutr Biochem, 2011; 22:681–690.

Rahman ST , Merchant N , Hague T , et al. The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: Results from the Quality Study. J Cardiovasc Pharmacol Ther, 2012; 17:139–145.

Huang YD , Li N , Zhang WG , et al. The effect of oral alpha-lipoic acid in overweight/obese individuals on the brachial-ankle pulse wave velocity and supine blood pressure: A randomized, crossover, double-blind, placebo-controlled trial. Zhonghua Liu Xing Bing Xue Za Zhi, 2011; 32:290–296.

Morcos M , Borcea V , Isermann B , et al. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: An exploratory study. Diabetes Res Clin Prac, 2001; 52:175–183.

Noori N , Tabibi H , Hosseinpanah F , et al. Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy. Int J Vitam Nutr Res, 2013; 83:77–85.

Hosseini S , Lee J , Sepulveda RT , et al. A randomized, double-blind, placebo-controlled, prospective 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutr Res, 2001; 21:1251–1260.

Zibadi S , Rohdewald PJ , Park D , Watson RR . Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr Res, 2008:28:315–320.

Liu X , Wei J , Tan F , et al. Pycnogenol French maritime pine bark extract improves endothelial function of hypertensive patients. Lif Sci, 2004; 74:855–862.

Van der Zwan LP , Scheffer PG , Teerlink T . Reduction of myeloperoxidase activity by melatonin and Pycnogenol may contribute to their blood pressure lowering effect. Hypertension, 2010; 56:e3–5.

Cesarone MR , Belcaro G , Stuard S , et al. Kidney flow and function in hypertension: Protective effects of Pycnogenol in hypertensive participants—a controlled study. J Cardiovasc Pharmacol Ther, 2010; 15:41–46.

Gulati OP . Pycnogenol in metabolic syndrome and related disorders. Phytother Res, 2015; 29:949–968.

Hu S , Belcaro G , Cornelli U , et al. Effects of Pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: The borderline study. Int Angiol, 2015; 34:43–52.

Enseleit F , Sudano I , Pé riat D , et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: A double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J, 2012; 33:1589–1597.

Luzzi R , Belcaro G , Hosoi M , et al. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol^® . Minerva Ginecol, 2017; 69:29–34.

Simons S , Wollersheim H , Thien T . A systematic review on the influence of trial quality on the effects of garlic on blood pressure. Neth J Med, 2009; 67:212–219.

Reinhard KM , Coleman CI , Teevan C , Vacchani P . Effects of garlic on blood pressure in patients with and without systolic hypertension: A meta-analysis. Ann Pharmacother, 2008:42:1766–1771.

Reid K , Frank OR , Stocks NP . Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: A randomized controlled trial. Maturitas, 2010; 67:144–150.

Nakasone Y , Nakamura Y , Yamamoto T , Yamaguchi H . Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Exp Ther Med, 2013; 5:399–405.

Ried K , Frank OR , Stocks NP . Aged garlic extract reduces blood pressure in hypertensives: A dose–response trial. Eur J Clin Nutr, 2013; 67:64–70.

Shouk R , Abdou A , Shetty K , et al. Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutr Res, 2014; 34:106–115.

Stabler SN , Tejani AM , Huynh F , Fowkes C . Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients. Cochrane Database Syst Rev, 2012; 8:CD00765–3.

Mahdavi-Roshan M , Nasrollahzadeh J , Mohammad Zadeh A , Zahedmehr A . Does garlic supplementation control blood pressure in patients with severe coronary artery disease? A clinical trial study. Iran Red Crescent Med J, 2016; 18:e2387–1.

Ried K , Travica N , Sali A . The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: The AGE at Heart Trial. Integr Blood Press Control, 2016; 9:9–21.

Varshney R Budoff MJ . Garlic and Heart Disease. J Nutr, 2016; 146:416S–421S.

Xiong XJ , Wang PQ Li SJ , Li XK , Zhang YQ , Wang J . Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 2015; 22:352–361.

Suetsuna K , Nakano T . Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem, 2000; 11:450–454.

Nakano T , Hidaka H , Uchida J , et al. Hypotensive effects of wakame. J Jpn Soc Clin Nutr, 1998; 20:9–2.

Krotkiewski M , Aurell M , Holm G , et al. Effects of a sodium-potassium ion-exchanging seaweed preparation in mild hypertension. Am J Hypertens, 1991; 4:483–488.

Sato M , Oba T , Yamaguchi T , et al. Antihypertensive effects of hydrolysates of wakame (Undaria pinnatifida) and their angiotnesin-1-converting inhibitory activity. Ann Nutr Metab, 2002; 46:259–267.

Sato M , Hosokawa T , Yamaguchi T , et al. Angiotensin I converting enzyme inhibitory peptide derived from wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J Agric Food Chem, 2002; 50:6245–6252.

Taubert D , Roesen R , Schomig E . Effect of cocoa and tea intake on blood pressure: A meta-analysis. Arch Intern Med, 2007; 167:626–634.

Grassi D , Lippi C , Necozione S , et al. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr, 2005; 81:611–614.

Taubert D , Roesen R , Lehmann C , et al. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: A randomized controlled trial. JAMA, 2007; 298:49–60.

Cohen DL , Townsend RR . Cocoa ingestion and hypertension-another cup please?. J Clin Hypertens, 2007; 9:647–648.

Reid I , Sullivan T , Fakler P , et al. Does chocolate reduce blood pressure? A meta-analysis. BMC Med, 2010; 8:39–46.

Egan BM , Laken MA , Donovan JL , Woolson RF . Does dark chocolate have a role in the prevention and management of hypertension? Commentary on the evidence. Hypertension, 2010; 55:1289–1295.

Desch S , Kobler D , Schmidt J , et al. Low vs higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens, 2010; 23:694–700.

Desch S , Schmidt J , Sonnabend M , et al. Effect of cocoa products on blood pressure: Systematic review and meta-analysis. Am J Hypertens, 2010; 23:97–103.

Grassi D , Desideri G , Necozione S , et al. Blood pressure is reduced and insulin sensitivity increased in glucose intolerant hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr, 2008; 138:1671–1676.

Grassi D , Necozione S , Lippi C , et al. Cocoa reduces blood pressure and insulin resistance and improved endothelium-dependent vasodilation in hypertensives. Hypertension, 2005; 46:398–405.

Grassi D , Desideri G , Necozione S , et al. Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia. Hypertension, 2012; 60:827–832.

Ried K , Sullivan TR , Fakler P , et al. Effect of cocoa on blood pressure. Cochrane Database Syst Rev, 2012; 8:CD00889–3.

Scheer FA , Van Montfrans GA , van Someren EJ , et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension, 2004; 43:192–197.

Cavallo A , Daniels SR , Dolan LM , et al. Blood pressure response to melatonin in type I diabetes. Pediatr Diabetes, 2004; 5:26–31.

Cavallo A , Daniels SR , Dolan LM , et al. Blood pressure-lowering effect of melatonin in type 1 diabetes. J Pineal Res, 2004; 36:262–266.

Cagnacci A , Cannoletta M , Renzi A , et al. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens, 2005; 18:1614–1618.

Grossman E , Laudon M , Yalcin R , et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med, 2006; 119:898–902.

Rechcinski T , Kurpese M , Trzoa E , Krzeminska-Pakula M . The influence of melatonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease—preliminary report. Pol Arch Med Wewn, 2006; 115:520–528.

Merkureva GA , Ryzhak GA . Effect of the pineal gland peptide preparation on the diurnal profile of arterial pressure in middle-aged and elderly women with ischemic heart disease and arterial hypertension. Adv Gerontol, 2008; 21:132–142.

Zaslavskai RM , Scherban EA , Logvinenki SI . Melatonin in combined therapy of patients with stable angina and arterial hypertension. Klin Med (Mosk), 2009:86:64–67.

Zamotaev IuN , Enikeev AKh , Kolomets NM . [The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production]. Klin Med (Mosk), 2009; 87:46–49.

Rechcinski T , Trzos E , Wierzbowski-Drabik K , et al. Melatonin for nondippers with coronary artery disease: Assessment of blood pressure profile and heart rate variability. Hypertens Res, 2002; 33:56–61.

Kozirog M , Poliwczak AR , Duchnowicz P , et al. Melatonin treatment improves blood pressure, lipid profile and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res, 2011; 50:261–266.

Zeman M , Dulkova K , Bada V , Herichova I . Plasma melatonin concentrations in hypertensive patients with the dipping and nondipping blood pressure profile. Life Sci, 2005; 75:1795–1803.

Jonas M , Garfinkel D , Zisapel N , et al. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Pressure, 2003; 12:19–24.

Simko F , Pechanova O . Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J Pineal Res, 2009; 47:127–133.

Cui HW , Zhang ZX , Gao MT , et al. [Circadian rhythm of melatonin and blood pressure changes in patients with essential hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi, 2008; 36:20–23.

Ostrowska Z , Kos-Kudla B , Marek B , et al. [Circadian rhythm of melatonin in patients with hypertension]. Pol Merkur Lekarski, 2004; 17:50–54.

Shatilo VB , Bondarenke EV , Amtoniuk-Shcheglova IA . Pineal gland melatonin-producing function in elderly patients with hypertensive disease: Age peculiarities. Adv Gerontol, 2010; 23:530–542.

Forman JP , Curhan GC , Schemhammer ES . Urinary melatonin and risk of incident hypertension among young women. J Hypertens, 2010; 28:336–351.

van der Zwan LP , Scheffer PG , Teerlink T . Reduction of myeloperoxidase activity by melatonin and Pycnogenol may contribute to their blood pressure lowering effect. Hypertension, 2010; 56:e3–5.

Li HL , Kang YM , Yu L , Xu HY , et al. Melatonin reduces blood pressure in rats with stress-induced hypertension via GABAA receptors. Clin Exp Pharmacol, 2009; 36:436–440.

Simko F , Paulis L . Melatonin as a potential antihypertensive treatment. J Pineal Res, 2007; 42:319–322.

Irmak MK , Sizlan A . Essential hypertension seems to result from melatonin-induced epigenetic modifications in area postrema. Med Hypotheses, 2006; 66:1000–1007.

De-Leersnyder H , de Biois MC , Vekemans M , et al. Beta (1) adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith–Magenis syndrome. J Med Genet, 2010; 38:586–590.

Rodella LF , Favero G , Foglio E , et al. Vascular endothelial cells and dysfunctions: Role of melatonin. Front Biosci, 2013; 5:119–129.

Grossman E , Laudon M , Zisapel N . Effect of melatonin on nocturnal blood pressure: Meta-analysis of randomized controlled trials. Vasc Health Risk Manag, 2011; 7:577–584.

Scheer FA , Morris CJ , Garcia JI , et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: A randomized controlled trial. Sleep, 2012; 35:1395–1402.

Zaslavskaya RM , Lilitsa GV , Dilmagambetova GS , et al. Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering. Biomed Pharmacother, 2004; 58:S129–S134.

Sun H , Gusdon AM , Qu S . Effects of melatonin on cardiovascular diseases: Progress in the past year. Curr Opin Lipidol, 2016; 27:408–413.

Feringa HH , Laskey DA , Dickson JE , Coleman CI . The effect of grape seed extract on cardiovascular risk markers: A meta-analysis of randomized controlled trials. J Am Diet Assoc, 2011; 111:1173–1181.

Sivaprakasapillai B , Edirsinghe K , Randolph J , et al. Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism, 2009; 58:1743–1746.

Edirisinghe I , Burton-Freeman B , Tissa Kappagoda C . Mechanism of the endothelium-dependent relaxation evoked by grape seed extract. Clin Sci (Lond), 2008; 114:331–337.

Zhang H , Liu S , Li L , et al. The impact of grape seed extract treatment on blood pressure changes: A meta-analysis of 16 randomized controlled trials. Medicine (Baltimore), 2016; 95:e424–7.

Park E , Edirisinghe I , Choy YY , et al. Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: A randomised, double-blinded, two-arm, parallel, placebo-controlled trial. Br J Nutr, 2016; 115:226–238.

Clements WT , Lee SR , Bloomer RJ . Nitrate ingestion: A review of the health and physical performance effects. Nutrients, 2014; 6:5224–5264.

Kapil V , Milsom AB , Okorie M , et al. Inorganic nitrate supplementation lowers blood pressure in humans: Role for nitrite-derived NO. Hypertension, 2010; 56:274–281.

Kapil V , Khambata RS , Robertson A , et al. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: A randomized, phase 2, double-blind, placebo-controlled study. Hypertension, 2015; 65:320–327.

Coles LT , Clifton PM . Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: A randomized, placebo-controlled trial. Nutr J, 2012; 11:10–6.

Siervo M , Lara J , Ogbonmwan I , Mathers JC . Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: A systematic review and meta-analysis. J Nutr, 2013; 143:818–826.

Houston M . Acute effects of an oral nitric oxide supplement on blood pressure, endothelial function, and vascular compliance in hypertensive patients. J Clin Hypertens (Greenwich), 2014; 16:524–529.

Kapil V , Khambata RS , Robertson A , et al. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: A randomized, phase 2, double-blind, placebo-controlled study. Hypertension, 2015; 65:320–327.

Hobbs DA , Kaffa N , George TW , et al. Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched bread products in normotensive male subjects. Br J Nutr, 2012; 108:2066–2074.

Kapil V , Pearl V , Ghosh S , Ahluwalia A . Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide, 2012; 26:197–202.

Asgary S , Afshani MR , Sahebkar A , et al. Improvement of hypertension, endothelial function and systemic inflammation following short-term supplementation with red beet (Beta vulgaris L.) juice: A randomized crossover pilot study. J Hum Hypertens, 2016; 30:627–632.

Bryan NS . Application of nitric oxide in drug discovery and development. Expert Opin Drug Discov, 2011; 6:1139–1154.

Machha A , Schechter AN . Inorganic nitrate: A major player in the cardiovascular health benefits of vegetables?. Nutr Rev, 2012; 70:367–372.

Liu G , Mi XN , Zheng XX , et al. Effects of tea intake on blood pressure: A meta-analysis of randomised controlled trials. Br J Nutr, 2014; 112:1043–1054.

Hodgson JM , Puddey IB , Burke V , et al. Effects on blood pressure of drinking green and black tea. J Hypertens, 1999; 17:457–463.

Kurita I , Maeda-Yamamoto M , Tachibana H , Kamei M . Anti-hypertensive effect of Benifuuki tea containing O-methylated EGCG. J Agric Food Chem, 2010; 58:1903–1908.

McKay DL , Chen CY , Saltzman E , Blumberg JB . Hibiscus sabdariffa L tea (tisane) lowers blood pressure in pre-hypertensive and mildly hypertensive adults. J Nutr, 2010; 140:298–303.

Bogdanski P , Suliburska J , Szulinska M , et al. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res, 2012; 32:421–427.

Hodgson JM , Woodman RJ , Puddey IB , et al. Short-term effects of polyphenol-rich black tea on blood pressure in men and women. Food Funct, 2013; 4:111–115.

170. Medina-Remón A, Estruch R , Tresserra-Rimbau A , et al. The effect of polyphenol consumption on blood pressure. Mini Rev Med Chem, 2013; 13:1137–1149.

171. Jimé nez R , Duarte J , Perez-Vizcaino F . Epicatechin: Endothelial function and blood pressure. J Agric Food Chem, 2012; 60:8823–8830.

Nogueira LP , Nogueira Neto JF , Klein MR , Sanjuliani AF . Short-term effects of green tea on blood pressure, endothelial function, and metabolic profile in obese prehypertensive women: A crossover randomized clinical trial. J Am Coll Nutr, 2017; 36:108–115.

Wasilewski R , Ubara EO , Klonizakis M . Assessing the effects of a short-term green tea intervention in skin microvascular function and oxygen tension in older and younger adults. Microvasc Res, 2016; 107:65–71.

Bogdanski P , Suliburska J , Szulinska M , et al. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res, 2012; 32:421–427.

Yarmolinsky J , Gon G , Edwards P . Effect of tea on blood pressure for secondary prevention of cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials. Nutr Rev, 2015; 73:236–246.

Houston MC . Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Exp Rev Cardiovasc Ther, 2007; 5:681–691.

Miguel-Carrasco JL , Monserrat MT , Mate A , Vá zquez CM . Comparative effects of captopril and L-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. Eur J Pharmacol, 2010; 632:65–72.

Zambrano S , Blanca AJ , Ruiz-Armenta MV , et al. L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression. Biochem Pharmacol, 2013; 85:937–944.

Vilskersts R , Kuka J , Svalbe B , et al. Administration of L-carnitine and mildronate improves endothelial function and decreases mortality in hypertensive Dahl rats. Pharmacol Rep, 2011; 63:752–762.

Mate A , Miguel-Carrasco JL , Monserrat MT , Vá zquez CM . Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension. J Physiol Biochem, 2010; 66:127–136.

Digiesi V , Cantini F , Bisi G , et al. L-carnitine adjuvant therapy in essential hypertension. Clin Ter, 1994; 144:391–395.

Ghidini O , Azzurro M , Vita G , Sartori G . Evaluation of the therapeutic efficacy of L-Carnitine in congestive heart failure. Int J Clin Pharmacol Ther Toxicol, 1988; 26:217–220.

Digiesi V , Palchetti R , Cantini F . The benefits of L-Carnitine therapy in essential arterial hypertension with diabetes mellitus type II. Minerva Med, 1989; 80:227–231.

Ruggenenti P , Cattaneo D , Loriga G , et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: Effects of acetyl-L-carnitine therapy. Hypertension, 2009; 54:567–574.

Martina V , Masha A , Gigliardi VR , et al. The therapeutic prospects of using L-carnitine to manage hypertension-related organ damage. Drug Discov Today, 2010; 15:484–492.

Korkmaz S , Yıldız G, Kılıçlı F, et al. [Low L-carnitine levels: Can it be a cause of nocturnal blood pressure changes in patients with type 2 diabetes mellitus?]. Anadolu Kardiyol Derg, 2011; 11:57–63.

Velasquez MT , Ramezani A , Manal A , Raj DS . Trimethylamine N-oxide: The good, the bad and the unknown. Toxins (Basel), 2016; 8:1–12.

He J , Whelton PK . Effect of dietary fiber and protein intake on blood pressure: A review of epidemiologic evidence. Clin Exp Hypertens, 1999; 21:785–796.

Pruijm M , Wuerzer G , Forni V , et al. Nutrition and hypertension: More than table salt. Rev Med Suisse, 2010; 6:1715–1720.

Cicero AF , Derosa G , Manca M , et al. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: A six-month, randomized clinical trial. Clin Exp Hypertens, 2007; 29:383–394.

Pal S , Khoussousi A , Binns C , et al. The effects of 12-week psyllium fibre supplementation or healthy diet on blood pressure and arterial stiffness in overweight and obese individuals. Br J Nutr, 2012; 107:725–734.

Houston MC . Nutrition and nutraceuticals supplements in the treatment of hypertension. Prog Cardiovasc Dis, 2005; 47:396–449.

Caligiuri SP , Edel AL , Aliani M , Pierce GN . Flaxseed for hypertension: Implications for blood pressure regulation. Curr Hypertens Rep, 2014; 16:49–9.

Sankar D , Sambandam G , Ramskrishna Rao M , Pugalendi KV . Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta, 2005; 355:97–104.

Sankar D , Rao MR , Sambandam G , Pugalendi KV . Effect of sesame oil on diuretics or beta-blockers in the modulation of blood pressure, anthropometry, lipid profile and redox status. Yale J Biol Med, 2006; 79:19–26.

Miyawaki T , Aono H , Toyoda-Ono Y , et al. Anti-hypertensive effects of sesamin in humans. J Nutr Sci Vitaminol (Toyko), 2009; 55:87–91.

Wichitsranoi J , Weerapreeyakui N , Boonsiri P , et al. Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensive humans. Nutr J, 2011; 10:82–88.

Sudhakar B , Kalaiarasi P , Al-Numair KS , et al. Effect of combination of edible oils on blood pressure, lipid profile, lipid peroxidative markers, antioxidant status, and electrolytes in patients with hypertension on nifedipine treatment. Saudi Med J, 2011; 32:379–385.

Sankar D , Rao MR , Sambandam G , Pugalendi KV . A pilot study of open label sesame oil in hypertensive diabetics. J Med Food, 2006; 9:408–412.

Harikumar KB , Sung B , Tharakan ST , et al. Sesamin manifests chemopreventive effects through the suppression of NF-kappa-B-regulated cell survival, proliferation, invasion and angiogenic gene products. Mol Cancer Res, 2010; 8:751–761.

Nakano D , Ogura K , Miyakoshi M , et al. Antihyptensive effect of angiotensin-I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. Biosci Biotechnol Biochem, 2006; 70:1118–1126.

Karatzi K , Stamatelopoulos K , Lykka M , et al. Acute and long-term hemodynamic effects of sesame oil consumption in hypertensive men. J Clin Hypertens (Greenwich), 2012; 14:630–636.

Plantinga Y , Ghiadone L , Magagna A , Biannarelli C . Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens, 2007; 20:392–397.

Sato K , Dohi Y , Kojima M , Miyagawa K . Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung, 2006; 56:535–540.

Block G , Mangels AR , Norkus EP , et al. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension, 2001; 37:261–267.

McRae MP . Is vitamin C an effective antihypertensive supplement? A review and analysis of the literature. J Chiropr Med, 2006; 5:60–64.

Simon JA . Vitamin C and cardiovascular disease: A review. J Am Coll Nutr, 1992; 11:107–125.

Ledlerc PC , Proulx CD , Arquin G , Belanger S . Ascorbic acid decreases the binding affinity of the AT1 Receptor for angiotensin II. Am J Hypertens, 2008:21:67–71.

Ness AR , Chee D , Elliott P . Vitamin C and blood pressure—An overview. J Hum Hypertens, 1997; 11:343–350.

Trout DL . Vitamin C and cardiovascular risk factors. Am J Clin Nutr, 1991; 53:322S–325S.

Morand C , Dubray C , Milenkovic D , et al. Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. Am J Clin Nutr, 2011; 93:73–80.

Massarenti P , Settanni F , Della Casa L , et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care, 2008; 31:940–944.

Jiang B , Haverty M , Brecher P . N-acetyl-L-cysteine enhances interleukin-1beta-induced nitric oxide synthase expression. Hypertension, 1999; 34:574–579.

Vasdev S , Singal P , Gill V . The antihypertensive effect of cysteine. Int J Angiol, 2009; 18:7–21.

Meister A , Anderson ME , Hwang O . Intracellular cysteine and glutathione delivery systems. J Am Coll Nutr, 1986; 5:137–151.

Asher GN , Viera AJ , Weaver MA , et al. Effect of hawthorn standardized extract on flow mediated dilation in prehypertensive and mildly hypertensive adults: A randomized, controlled cross-over trial. BMC Complement Altern Med, 2012; 12:26–30.

217. Koç yildiz ZC , Birman H , Olgaç V, et al. Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: A morphological study. Phytother Res, 2006; 20:66–70.

218. Schrö der D , Weiser M , Klein P . Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: Results of an observational cohort study. Eur J Heart Fail, 2003; 5:319–326.

Walker AF , Marakis G , Simpson E , et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: A randomised controlled trial. Br J Gen Pract, 2006; 56:437–443.

Walker AF , Marakis G , Morris AP , Robinson PA . Promising hypotensive effect of hawthorn extract: A randomized double-blind pilot study of mild, essential hypertension. Phytother Res, 2002; 16:48–54.

Larson A , Witman MA , Guo Y , et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: Nitric oxide. Nutr Res, 2012; 32:557–564.

Edwards RL , Lyon T , Litwin SE , et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr, 2007; 137:2405–2411.

Egert S , Bosy-Westphal A , Seiberl J , et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br J Nutr, 2009; 102:1065–1074.

Dong JY , Szeto IM , Makinen K , et al. Effect of probiotic fermented milk on blood pressure: A meta-analysis of randomised controlled trials. Br J Nutr, 2013; 110:1188–1194.

Khalesi S , Sun J , Buys N , Jayasinghe R . Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Hypertension, 2014; 64:897–903.

Hendijani F , Akbari V . Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: A systematic review and meta-analysis. Clin Nutr, 2018; 37:532–541.

Robles-Vera I , Toral M , Romero M , et al. Antihypertensive effects of probiotics. Curr Hypertens Rep, 2017; 19:2–6.

de Sousa VP , Cavalcanti Neto MP , Magnani M , et al. New insights on the use of dietary polyphenols or probiotics for the management of arterial hypertension. Front Physiol, 2016; 7:448–460.

Daliri EB , Lee BH , Oh DH . Current perspectives on antihypertensive probiotics. Probiotics Antimicrob Proteins, 2017; 9:91–101.

Houston MC . Treatment of hypertension with nutrition and nutraceutical supplements: Part 1. Altern Complement Ther, 2018; 24:260–275.

Trovato A , Nuhlicek DN , Midtling JE . Drug–nutrient interactions. Am Fam Physician, 1991; 44:1651–1658.

McCabe BJ , Frankel EH , Wolfe JJ , eds. Handbook of Food–Drug Interactions. Boca Raton, FL: CRC Press, 2003.

Houston MC . The role of cellular micronutrient analysis and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis, 2010; 4:165–183.